InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the detailed record of transactions filed by Tucker Edwin Jonathan, Directeur Médical. Insider active across 2 companies, notably Mirum Pharmaceuticals, Inc.. Cumulatively, 4 reports have been recorded. Activity tracked since 10 May 2021. The latest transaction was disclosed on 7 June 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Tucker Edwin Jonathan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报4 总计
400 股@ US$4.1735100.0% 占其流量Voting Common StockSEC:0001213900-24-051417:0
70 股@ US$13.5154.4% 占其流量Common StockSEC:0001209191-21-064453:0
8,125 股0Common StockSEC:0001209191-21-058604:0
1,483 股@ US$14.6295.6% 占其流量Common StockSEC:0001209191-21-032163:0
4 条申报中的 4 条
About Tucker Edwin Jonathan
Edwin Jonathan Tucker is the Chief Medical Officer of Mirum Pharmaceuticals, Inc. In this role, he oversees the company's medical and scientific initiatives. His expertise in the pharmaceutical sector allows him to lead research and development projects. He is committed to promoting innovation and improving patient outcomes.
